Understanding and Predicting the Effect of Cocrystal Components and pH on Cocrystal Solubility

被引:151
作者
Bethune, Sarah J. [1 ]
Huang, Neal [1 ]
Jayasankar, Adivaraha [1 ]
Rodriguez-Hornedo, Nair [1 ]
机构
[1] Univ Michigan, Dept Pharmaceut Sci, Ann Arbor, MI 48109 USA
关键词
PHARMACEUTICAL PHASES; SALTS; CRYSTALLIZATION; DISSOLUTION; SACCHARIN; BASE; DRUG;
D O I
10.1021/cg9001187
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Understanding flow cocrystal solubility-pH dependence is affected by cocrystal components is important to engineer cocrystals with customized solubility behavior. Equations that describe cocrystal solubility in terms of solubility product, cocrystal component. ionization constants, and solution pH are derived for cocrystals with acidic, basic, amphoteric, and zwitterionic components. Studies with carbamazepine-salicylic acid and carbamazepine-4-aminobenzoic acid show that cocrystals of a nonionizable drug achieve pH-dependent solubility when cocrystallized with ionizable coformers. These findings are in good agreement with predicted behavior and provide insight on the ability of coformer to determine the shape of the pH-solubility curve, It is shown that measurement of solution concentrations and pH at the eutectic point, C-tr, is valuable to (a) estimate cocrystal solubility-pH dependence, (b) evaluate the effectiveness of coformer in stabilizing or precipitating cocrystal, and (c) guide cocrystal selection without the time and material consuming determination of full phase solubility diagrams.
引用
收藏
页码:3976 / 3988
页数:13
相关论文
共 36 条
[1]   PREDICTIVE RELATIONSHIPS IN THE WATER SOLUBILITY OF SALTS OF A NONSTEROIDAL ANTI-INFLAMMATORY DRUG [J].
ANDERSON, BD ;
CONRADI, RA .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1985, 74 (08) :815-820
[2]   Solubility of sparingly-soluble ionizable drugs [J].
Avdeef, Alex .
ADVANCED DRUG DELIVERY REVIEWS, 2007, 59 (07) :568-590
[3]   Saccharin salts of active pharmaceutical ingredients, their crystal structures, and increased water solubilities [J].
Banerjee, R ;
Bhatt, PM ;
Ravindra, NV ;
Desiraju, GR .
CRYSTAL GROWTH & DESIGN, 2005, 5 (06) :2299-2309
[4]   Saccharin as a salt former. Enhanced solubilities of saccharinates of active pharmaceutical ingredients [J].
Bhatt, PM ;
Ravindra, NV ;
Banerjee, R ;
Desiraju, GR .
CHEMICAL COMMUNICATIONS, 2005, (08) :1073-1075
[5]   Structure, solubility, screening, and synthesis of molecular salts [J].
Black, Simon N. ;
Collier, Edwin A. ;
Davey, Roger J. ;
Roberts, Ron J. .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2007, 96 (05) :1053-1068
[6]   SOLUBILITY OF DOXYCYCLINE IN AQUEOUS-SOLUTION [J].
BOGARDUS, JB ;
BLACKWOOD, RK .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1979, 68 (02) :188-194
[7]   Screening strategies based on solubility and solution composition generate pharmaceutically acceptable cocrystals of carbamazepine [J].
Childs, Scott L. ;
Rodriguez-Hornedo, Nair ;
Reddy, L. Sreenivas ;
Jayasankar, Adivaraha ;
Maheshwari, Chinmay ;
McCausland, Linda ;
Shipplett, Rex ;
Stahly, Barbara C. .
CRYSTENGCOMM, 2008, 10 (07) :856-864
[8]   Cocrystals of piroxicam with carboxylic acids [J].
Childs, Scott L. ;
Hardcastle, Kenneth I. .
CRYSTAL GROWTH & DESIGN, 2007, 7 (07) :1291-1304
[9]   On the solubility of saccharinate salts and cocrystals [J].
Cooke, Claire L. ;
Davey, Roger J. .
CRYSTAL GROWTH & DESIGN, 2008, 8 (10) :3483-3485
[10]   Crystal engineering of the composition of pharmaceutical phases:: Multiple-component crystalline solids involving carbamazepine [J].
Fleischman, SG ;
Kuduva, SS ;
McMahon, JA ;
Moulton, B ;
Walsh, RDB ;
Rodríguez-Hornedo, N ;
Zaworotko, MJ .
CRYSTAL GROWTH & DESIGN, 2003, 3 (06) :909-919